New stimulant EB-1020 put to the test: will it be abused?
NCT ID NCT02144415
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a new drug called EB-1020 has abuse potential in 80 healthy adults who use stimulants recreationally. Participants received single doses of EB-1020, d-amphetamine, or placebo, and rated how much they liked the drug. The goal was to see if EB-1020 produces a 'high' similar to other stimulants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
EB-1020 immediate-release capsules
What this could lead to
If EB-1020 shows low abuse potential, it may be developed as a safer stimulant alternative for conditions like ADHD.
What could go wrong
This is an early Phase 1 study in healthy volunteers, not patients. The results may not predict real-world abuse or effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vince and Associates Clinical Research, Inc.
Overland Park, Kansas, 66212, United States